L
Lybrate
mobile-based platform connects patients and doctors
About Lybrate
Lybrate is an innovative online platform that connects patients with certified doctors for consultations, treatments, and health advice. Operating primarily in the Indian healthcare market, Lybrate serves a wide range of clients, including individuals seeking medical advice, treatment, and second opinions. The platform offers a user-friendly interface where patients can consult doctors online, book appointments, and access a wealth of medical information.
Lybrate's business model revolves around providing a seamless connection between patients and healthcare providers. It generates revenue through subscription fees from doctors who wish to be listed on the platform, as well as through consultation fees paid by patients. Additionally, Lybrate offers premium services such as detailed health reports and personalized health plans, which contribute to its revenue stream.
The company leverages technology to revolutionize healthcare delivery, making it more accessible and efficient. By offering a digital solution, Lybrate addresses the challenges of geographical barriers and limited access to healthcare professionals, particularly in remote areas.
Source: Dealroom company dataAt a glance
- Founded
- 2013
- Headquarters
- India
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Nexus Venture Partners
Sandeep Alluri
Tiger Global
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lybrate on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lybrate on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.